Purification of Recombinant α-synuclein : A Comparison of Commonly Used Protocols

The initial state of the intrinsically disordered protein α-synuclein (aSyn), e.g., the presence of oligomers and degradation products, or the presence of contaminants and adducts can greatly influence the aggregation kinetics and toxicity of the protein. Here, we compare four commonly used protocols for the isolation of recombinant aSyn from Escherichia coli: boiling, acid precipitation, ammonium sulfate precipitation, and periplasmic lysis followed by ion exchange chromatography and gel filtration. We identified, using nondenaturing electrospray ionization mass spectrometry, that aSyn isolated by acid precipitation and periplasmic lysis was the purest and yielded the highest percentage of monomeric protein, 100% and 96.5%, respectively. We then show that aSyn purified by the different protocols exerts different metabolic stresses in cells, with the more multimeric/degraded and least pure samples leading to a larger increase in cell vitality. However, the percentage of monomeric protein and the purity of the samples did not correlate with aSyn aggregation propensity. This study highlights the importance of characterizing monomeric aSyn after purification, as the choice of purification method can significantly influence the outcome of a subsequent study.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:59

Enthalten in:

Biochemistry - 59(2020), 48 vom: 08. Dez., Seite 4563-4572

Sprache:

Englisch

Beteiligte Personen:

Stephens, Amberley D [VerfasserIn]
Matak-Vinkovic, Dijana [VerfasserIn]
Fernandez-Villegas, Ana [VerfasserIn]
Kaminski Schierle, Gabriele S [VerfasserIn]

Links:

Volltext

Themen:

Alpha-Synuclein
Comparative Study
Evaluation Study
Intrinsically Disordered Proteins
Journal Article
Protein Aggregates
Recombinant Proteins
Research Support, Non-U.S. Gov't
SNCA protein, human

Anmerkungen:

Date Completed 05.04.2021

Date Revised 01.02.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.biochem.0c00725

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318043955